GlassScriptPhysician profile
Parag Butala
NPI 1245498443
$6,982.08
in general payments reported to CMS, 2019-2025
21 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,407 · 2020: $332 · 2021: $291 · 2022: $434 · 2023: $1,020 · 2024: $457 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,517.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $2,342.24 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Allergan, INC. | $1,531.42 | 2019-2022 | |
| Kci USA, INC. | $1,148.51 | 2019 | |
| Abbvie INC. | $902.55 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Merz North America, INC. | $295.27 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $144.34 | 2019-2025 | |
| Access Pro Medical, LLC | $90.25 | 2023 | Matriderm |
| Integra Lifesciences Corporation | $81.97 | 2021-2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Sientra, INC. | $76.67 | 2020-2022 | |
| Medical Device Business Services, INC. | $76.56 | 2020 | |
| Davol INC. | $62.84 | 2022 | |
| Solventum Corporation | $38.92 | 2025 | Activ.A.C. |
| Organogenesis INC. | $31.76 | 2025 | Cygnus Dual |
| Galderma Laboratories, L.P. | $29.97 | 2019-2021 | |
| Stryker Corporation | $25.20 | 2023 | Stryker |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $24.38 | 2023 | Aponvie |
| Vertex Pharmaceuticals Incorporated | $22.44 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $16.18 | 2023 | Exparel |
| Sun Pharmaceutical Industries INC. | $14.43 | 2020 | |
| Tela Bio, INC. | $14.28 | 2022 | |
| Dusa Pharmaceuticals, INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parag Butala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.